UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 213

Sortiert nach

Decline in Tested and Self-Reported Cognitive Functioning After Prophylactic Cranial Irradiation for Lung Cancer: Pooled Secondary Analysis of Radiation Therapy Oncology Group Randomized Trials 0212 and 0214

International journal of radiation oncology, biology, physics, 2013-07, Vol.86 (4), p.656-664

2013

Link zum Volltext

Verfügbarkeit prüfen

Prophylactic cranial irradiation for patients with lung cancer

The lancet oncology, 2016-07, Vol.17 (7), p.e277-e293

2016

Link zum Volltext

Verfügbarkeit prüfen

Higher Biologically Effective Dose of Radiotherapy Is Associated With Improved Outcomes for Locally Advanced Non–Small Cell Lung Carcinoma Treated With Chemoradiation: An Analysis of the Radiation Therapy Oncology Group

International journal of radiation oncology, biology, physics, 2012-01, Vol.82 (1), p.425-434

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Primary Analysis of Radiation Therapy Oncology Group Study RTOG 0214

Journal of clinical oncology, 2011-01, Vol.29 (3), p.272-278

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial of Prophylactic Cranial Irradiation Compared With Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Neurocognitive and Quality-of-Life Analysis

Journal of clinical oncology, 2011-01, Vol.29 (3), p.279-286

2011

Link zum Volltext

Verfügbarkeit prüfen

Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910

Journal of clinical oncology, 2015-02, Vol.33 (4), p.332-339

2015

Link zum Volltext

Verfügbarkeit prüfen

Limited‐Stage Small Cell Lung Cancer: Current Chemoradiotherapy Treatment Paradigms

The oncologist (Dayton, Ohio), 2010-02, Vol.15 (2), p.187-195

2010

Link zum Volltext

Verfügbarkeit prüfen

Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer

Cancers, 2023-04, Vol.15 (9), p.2523

2023

Link zum Volltext

Verfügbarkeit prüfen

Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Lung Cancer

Clinical lung cancer, 2019-11, Vol.20 (6), p.435-441

2019

Link zum Volltext

Verfügbarkeit prüfen

Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408

International journal of radiation oncology, biology, physics, 2015-07, Vol.92 (4), p.863-873

2015

Link zum Volltext

Verfügbarkeit prüfen

Self-Expanding Metal Stents Improve Swallowing and Maintain Nutrition During Neoadjuvant Therapy for Esophageal Cancer

Digestive diseases and sciences, 2017-06, Vol.62 (6), p.1647-1656

2017

Link zum Volltext

Verfügbarkeit prüfen

Select Patients With “Limited” Extensive-Stage Small Cell Lung Cancer Should Be Treated Aggressively

International journal of radiation oncology, biology, physics, 2018-05, Vol.101 (1), p.6-7

Gore, Elizabeth M.

2018

Link zum Volltext

Verfügbarkeit prüfen

Development of a comprehensive cardiac atlas on a 1.5 Tesla Magnetic Resonance Linear Accelerator

Physics and imaging in radiation oncology, 2023-10, Vol.28, p.100504-100504, Article 100504

2023

Link zum Volltext

Verfügbarkeit prüfen

Value CMR: Towards a Comprehensive, Rapid, Cost-Effective Cardiovascular Magnetic Resonance Imaging

International journal of biomedical imaging, 2021, Vol.2021, p.8851958-12

2021

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: an analysis of Veterans Health Administration data

Journal of clinical oncology, 2015-02, Vol.33 (6), p.567-574

2015

Link zum Volltext

Verfügbarkeit prüfen

Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408

Advances in radiation oncology, 2017-10, Vol.2 (4), p.608-614

2017

Link zum Volltext

Verfügbarkeit prüfen

Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients With Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy

International journal of radiation oncology, biology, physics, 2024-02, Vol.118 (2), p.404-414

2024

Link zum Volltext

Verfügbarkeit prüfen

Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.370-377

2023

Link zum Volltext

Verfügbarkeit prüfen

Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: An ASTRO outcomes initiative

International journal of radiation oncology, biology, physics, 2005-05, Vol.62 (1), p.3-19

2005

Link zum Volltext

Verfügbarkeit prüfen

Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415

Radiotherapy and oncology, 2019-06, Vol.135, p.19-24

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 213

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(193)
Mit Volltextzugriff
(189)

Publikationsform

Sprache

Englisch
(212)
Japanisch
(29)

Erscheinungsjahr

n.n

Thema

Science & Technology
(144)
Life Sciences & Biomedicine
(141)
Humans
(125)
Male
(77)
Female
(68)
Oncology
(62)
Middle Aged
(48)
Aged
(46)
Biological And Medical Sciences
(45)
Medical Sciences
(44)
Adult
(34)
Radiology, Nuclear Medicine & Medical Imaging
(27)
Aged, 80 And Over
(26)
Treatment Outcome
(20)
Lung Neoplasms - Radiotherapy
(16)
Neoplasm Staging
(16)
Patients
(16)
Hematology, Oncology And Palliative Medicine
(15)
Quality Of Life
(15)
United States
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Decline in Tested and Self-Reported Cognitive Functioning After Prophylactic Cranial Irradiation for Lung Cancer: Pooled Secondary Analysis of Radiation Therapy Oncology Group Randomized Trials 0212 and 0214

Prophylactic cranial irradiation for patients with lung cancer

Higher Biologically Effective Dose of Radiotherapy Is Associated With Improved Outcomes for Locally Advanced Non–Small Cell Lung Carcinoma Treated With Chemoradiation: An Analysis of the Radiation Therapy Oncology Group

Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937

Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Primary Analysis of Radiation Therapy Oncology Group Study RTOG 0214

Phase III Trial of Prophylactic Cranial Irradiation Compared With Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Neurocognitive and Quality-of-Life Analysis

Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910

Limited‐Stage Small Cell Lung Cancer: Current Chemoradiotherapy Treatment Paradigms

Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer

Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Lung Cancer

Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408

Self-Expanding Metal Stents Improve Swallowing and Maintain Nutrition During Neoadjuvant Therapy for Esophageal Cancer

Select Patients With “Limited” Extensive-Stage Small Cell Lung Cancer Should Be Treated Aggressively

Development of a comprehensive cardiac atlas on a 1.5 Tesla Magnetic Resonance Linear Accelerator

Value CMR: Towards a Comprehensive, Rapid, Cost-Effective Cardiovascular Magnetic Resonance Imaging

Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial

Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: an analysis of Veterans Health Administration data

Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01

Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408

Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients With Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy

Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial

Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial

Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized Trial

Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: An ASTRO outcomes initiative

Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415

Suchergebnisse filtern